AMERIPRISE FINANCIAL INC - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$221,072
-1.9%
6,268
+5.7%
0.00%
Q2 2023$225,437
+12.0%
5,931
+11.3%
0.00%
Q1 2023$201,260
-14.7%
5,330
-4.1%
0.00%
Q4 2022$236,000
+15.1%
5,558
-2.0%
0.00%
Q1 2022$205,000
-58.5%
5,669
-54.6%
0.00%
Q4 2021$494,000
+93.7%
12,481
+113.1%
0.00%
Q3 2021$255,000
+10.9%
5,858
+4.1%
0.00%
Q2 2021$230,000
-0.9%
5,626
-20.1%
0.00%
Q1 2021$232,000
-84.3%
7,043
-80.6%
0.00%
-100.0%
Q4 2020$1,478,000
+20.3%
36,367
+8.4%
0.00%
Q3 2020$1,229,000
+502.5%
33,557
+459.5%
0.00%
Q2 2020$204,000
-77.1%
5,998
-85.7%
0.00%
Q1 2020$891,000
-3.3%
42,069
+1.9%
0.00%
Q4 2019$921,000
+11.4%
41,273
+1.0%
0.00%
Q3 2019$827,000
+9088.9%
40,852
+9080.2%
0.00%
Q3 2014$9,000
+200.0%
445
+256.0%
0.00%
Q2 2014$3,000
+50.0%
125
+7.8%
0.00%
Q1 2014$2,0001160.00%
Other shareholders
GENMAB A/S shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 242,848$9,169,9403.80%
Capricorn Fund Managers Ltd 110,643$4,177,8801.28%
Arlington Capital Management, Inc. 35,591$1,343,9161.26%
XY Capital Ltd 76,884$2,903,1401.13%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 88,000$3,322,8800.93%
TORRAY INVESTMENT PARTNERS LLC 110,807$4,184,0720.75%
Hardman Johnston Global Advisors LLC 585,139$22,094,8490.72%
Yorktown Management & Research Co Inc 16,600$626,8160.68%
First Light Asset Management, LLC 160,025$6,042,5440.54%
MIRABELLA FINANCIAL SERVICES LLP 28,260$2,505,8550.38%
View complete list of GENMAB A/S shareholders